Pfizer earnings beat by $0.34, revenue topped estimates

This post was originally published on this site

https://i-invdn-com.investing.com/news/LYNXMPEC0800S_M.jpg

Pfizer’s stock price closed at $46.55. It is down -6.64% in the last 3 months and up 2.42% in the last 12 months.

Pfizer saw 1 positive EPS revisions and 13 negative EPS revisions in the last 90 days. See Pfizer’s stock price’s past reactions to earnings here.

According to InvestingPro, Pfizer’s Financial Health score is “excellent performance“.

Check out Pfizer’s recent earnings performance, and Pfizer’s financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar